Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells (Scientific Reports, (2019), 9, 1, (6136), 10.1038/s41598-019-42237-3)
Document Type
Journal Article
Publication Date
12-1-2019
Journal
Scientific Reports
Volume
9
Issue
1
DOI
10.1038/s41598-019-51403-6
Abstract
© 2019, The Author(s). An amendment to this paper has been published and can be accessed via a link at the top of the paper.
APA Citation
Knox, T., Sahakian, E., Banik, D., Hadley, M., Palmer, E., Noonepalle, S., Kim, J., Powers, J., Gracia-Hernandez, M., Oliveira, V., Cheng, F., Chen, J., Barinka, C., Pinilla-Ibarz, J., Lee, N., Kozikowski, A., & Villagra, A. (2019). Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells (Scientific Reports, (2019), 9, 1, (6136), 10.1038/s41598-019-42237-3). Scientific Reports, 9 (1). http://dx.doi.org/10.1038/s41598-019-51403-6